-
EP2926815
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2926815
| EP2926815 - New derivatives of cephalosporin for treating cancer [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.10.2018 Database last updated on 22.08.2024 | |
| Former | Examination is in progress Status updated on 05.01.2018 | Most recent event Tooltip | 12.10.2018 | Application deemed to be withdrawn | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Institut Curie 26, rue d'Ulm 75248 Paris Cedex 05 / FR | For all designated states Harmonic Pharma 615 rue du Jardin Botanique Espace Transfert 54600 Villers-les-Nancy / FR | [2015/41] | Inventor(s) | 01 /
Karaboga, Arnaud Sinan 24 rue de Plobsheim 67100 Strasbourgh / FR | 02 /
Pérez-Nueno, Violeta Isabel c/Jaume I, 62 Bajos 1a 08840 Viladecans, Barcelona / ES | 03 /
Souchet, Michel 66 rue de Madrid 91190 Gif sur Yvettte / FR | 04 /
Decaudin, Didier M. 117 rue d'Estienne d'orves 91370 Verrieres le Buisson / FR | [2015/51] |
| Former [2015/41] | 01 /
Karaboga, Arnaud Sinan 24 rue de Plobsheim 67100 Strasbourgh / FR | ||
| 02 /
Pérez-Nueno, Violeta Isabel c/Jaume I, 62 Bajos 1a 08840 Viladecans, Barcelona / ES | |||
| 03 /
Souchet, Michel 66 rue de Madrid 91190 Gif sur Yvettte / FR | Representative(s) | Gallois, Valérie, et al Cabinet Becker & Associés 25, rue Louis le Grand 75002 Paris / FR | [2015/41] | Application number, filing date | 14305487.2 | 03.04.2014 | [2015/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2926815 | Date: | 07.10.2015 | Language: | EN | [2015/41] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.06.2014 | Classification | IPC: | A61K31/545, A61P35/00 | [2015/41] | CPC: |
A61K31/545 (EP,US);
A61K45/06 (EP,US);
A61K47/32 (US);
A61P11/00 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
| C-Set: |
A61K31/545, A61K2300/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/15] |
| Former [2015/41] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Cephalosporinderivate zur Behandlung von Krebs | [2015/41] | English: | New derivatives of cephalosporin for treating cancer | [2015/41] | French: | Dérivés de céphalosporines pour traiter le cancer | [2015/41] | Examination procedure | 07.03.2016 | Examination requested [2016/15] | 05.01.2018 | Despatch of a communication from the examining division (Time limit: M04) | 16.05.2018 | Application deemed to be withdrawn, date of legal effect [2018/46] | 12.06.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/46] | Fees paid | Renewal fee | 26.04.2016 | Renewal fee patent year 03 | 06.04.2017 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.04.2018 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO02096430 (KYLIX B V [NL], et al) [A] 1-15 * page 24 * * figures *; | [A]WO2006069449 (UNIV BRITISH COLUMBIA [CA], et al) [A] 1-15 * page 90, lines 15-26 * * claims 1, 5, 7, 27-29 *; | [A] - LI XIANG ET AL, "Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.", CARCINOGENESIS DEC 2012, (201212), vol. 33, no. 12, ISSN 1460-2180, pages 2548 - 2557, XP002724532 [A] 1-15 * abstract * * figure 1A * DOI: http://dx.doi.org/10.1093/carcin/bgs283 | [A] - OLER A, "ENDOGENOUS CYTOTOXICITY OF CEPHALOSPORINS", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, (19920101), vol. 6, no. 5, ISSN 0892-6638, page A1619, XP009178021 [A] 1-15 * abstract * | [A] - DOMANSKA URSZULA M ET AL, "A review on CXCR4/CXCL12 axis in oncology: no place to hide.", EUROPEAN JOURNAL OF CANCER (OXFORD, ENGLAND : 1990) JAN 2013, (201301), vol. 49, no. 1, ISSN 1879-0852, pages 219 - 230, XP002724533 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.ejca.2012.05.005 | by applicant | WO02096430 | WO02099430 | - DOMANSKA ET AL., EUROPEAN JOURNAL OF CANCER, (2013), vol. 49, pages 219 - 230 | - LI, CARCINOGENESIS, (2012), vol. 33, pages 2548 - 2557 | - J. PHARM. SCI., (1977), vol. 66, page 2 | - ZHOU, Y. ET AL., J. BIOL. CHEM., (2002), vol. 227, pages 49481 - 87 | - ZHOU, Y., J. BIOL. CHEM., vol. 277, pages 49481 - 49487 | - NEMATI ET AL., CLIN CANCER RES., (200005), pages 2075 - 86 |